Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

Université de Montréal

$10,000.00

Nuclear Transport Meeting 2022

FY 2021-22

Summary
A hallmark feature of eukaryotic cells is the separation of nuclear and cytoplasmic compartments by the nuclear membrane. The bidirectional transfer of macromolecules between these compartments occurs through a large proteins complex termed the nuclear pore complex (NPC). This transport of macromolecules through the NPC is highly regulated and dynamic. Consistent with the central role of nucleocytoplasmic transport in the regulation of many crucial processes required for cells to function, defects in this process, either by mutations or misregulation of factors involved in this process, is associated with many disease phenotypes, including cancer, neurodegenerative diseases such as ALS, muscular dystrophy and premature aging syndrome. Moreover, interactions with the transport machinery are central for many viruses to replicate. A better understanding of this complex process is therefore essential to better understand various diseases, as well as to allow finding possible treatments of various diseases, and has been an active research field for many years. The Nuclear Transport Meeting 2022, which takes place for the 14th time on September 18-23, 2022, at Estérel Resort, Quebec, Canada, brings together the leaders of the nuclear transport field to share their research and to discuss progress and challenges in the field. Delayed for a year due to the COVID pandemic, this meeting will be an important opportunity for the research community to reconnect, as well as allow the Canadian nuclear transport community to better integrate at the international stage.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
461063
Name
Zenklusen Daniel R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Planning and Dissemination - Institute of Genetics
Projecttitle
Nuclear Transport Meeting 2022
Programtype2
Miscellaneous Programs
Orgnameinp2
Université de Montréal
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Meeting; Nuclear Transport
Abstract
A hallmark feature of eukaryotic cells is the separation of nuclear and cytoplasmic compartments by the nuclear membrane. The bidirectional transfer of macromolecules between these compartments occurs through a large proteins complex termed the nuclear pore complex (NPC). This transport of macromolecules through the NPC is highly regulated and dynamic. Consistent with the central role of nucleocytoplasmic transport in the regulation of many crucial processes required for cells to function, defects in this process, either by mutations or misregulation of factors involved in this process, is associated with many disease phenotypes, including cancer, neurodegenerative diseases such as ALS, muscular dystrophy and premature aging syndrome. Moreover, interactions with the transport machinery are central for many viruses to replicate. A better understanding of this complex process is therefore essential to better understand various diseases, as well as to allow finding possible treatments of various diseases, and has been an active research field for many years. The Nuclear Transport Meeting 2022, which takes place for the 14th time on September 18-23, 2022, at Estérel Resort, Quebec, Canada, brings together the leaders of the nuclear transport field to share their research and to discuss progress and challenges in the field. Delayed for a year due to the COVID pandemic, this meeting will be an important opportunity for the research community to reconnect, as well as allow the Canadian nuclear transport community to better integrate at the international stage.
Competitiondate
202202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zenklusen, Daniel R
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Genetics~ $10,000~ $0~